Severe kerion Celsi caused by Trichophyton quinckeanum

IF 2.2 4区医学 Q3 MYCOLOGY Journal de mycologie medicale Pub Date : 2023-11-17 DOI:10.1016/j.mycmed.2023.101453

M. Lefranc , S. Fourmond , A. Jabet , A-C Normand , D. Girard , I. Accoceberry , F. Gabriel , L. Delhaes , S. Imbert

{"title":"Severe kerion Celsi caused by Trichophyton quinckeanum","authors":"M. Lefranc , S. Fourmond , A. Jabet , A-C Normand , D. Girard , I. Accoceberry , F. Gabriel , L. Delhaes , S. Imbert","doi":"10.1016/j.mycmed.2023.101453","DOIUrl":null,"url":null,"abstract":"<div>We report a severe case of kerion Celsi of the scalp in a previously healthy 13-year-old girl due to Trichophyton quinckeanum, an emerging dermatophyte species in Europe. The species was definitely identified by DNA sequencing and the patient was successfully treated by oral terbinafine for 6 weeks.Kerion Celsi is a severe inflammatory form of tinea capitis, which is characterised by a purulent discharge and alopecia [1]. It typically occurs in children infected with zoophilic dermatophytes, such as Trichophyton mentagrophytes, and an increasing number of cases caused by other Trichophyton species has recently been reported [2]. Herein we report a severe case of kerion Celsi of the scalp caused by the emerging species Trichophyton quinckeanum, which was successfully treated by oral antifungal.</div>","PeriodicalId":14824,"journal":{"name":"Journal de mycologie medicale","volume":"34 1","pages":"Article 101453"},"PeriodicalIF":2.2000,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal de mycologie medicale","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1156523323000975","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MYCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

We report a severe case of kerion Celsi of the scalp in a previously healthy 13-year-old girl due to Trichophyton quinckeanum, an emerging dermatophyte species in Europe. The species was definitely identified by DNA sequencing and the patient was successfully treated by oral terbinafine for 6 weeks.

Kerion Celsi is a severe inflammatory form of tinea capitis, which is characterised by a purulent discharge and alopecia [1]. It typically occurs in children infected with zoophilic dermatophytes, such as Trichophyton mentagrophytes, and an increasing number of cases caused by other Trichophyton species has recently been reported [2]. Herein we report a severe case of kerion Celsi of the scalp caused by the emerging species Trichophyton quinckeanum, which was successfully treated by oral antifungal.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

由毛癣菌（Trichophyton quinckeanum）引起的严重角化症

我们报告了一个严重的病例kerion Celsi的头皮在一个以前健康的13岁女孩由于毛癣菌quinckeanum，一个新兴的皮肤真菌物种在欧洲。通过DNA测序确定了该物种，并成功口服特比萘芬治疗6周。角质瘤是头癣的一种严重炎症形式，其特征是脓性分泌物和脱发[1]。它通常发生在感染了嗜兽性皮肤真菌(如毛癣菌)的儿童中，最近也报道了越来越多的由其他毛癣菌引起的病例[2]。我们在此报告一例由新出现的毛癣菌(Trichophyton quinckeanum)引起的严重头皮角质细胞病，经口服抗真菌药物治疗成功。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal de mycologie medicale 医学-真菌学

CiteScore

5.10

自引率

2.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity. JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered. Under no circumstances does the journal guarantee publication before the editorial board makes its final decision. The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.